Margins Lower On R&D Spends: Laurus Labs

Q1 Review | Laurus Labs' Founder Shares Earnings Insights

Q3 Review| Laurus Labs Growth Strategies For Coming Quarters

Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter

Laurus Labs Forays Into Biotech Segment Via Acquisition

Laurus Labs In Focus | Ask Profit | NDTV Profit

Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets

Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point

Stocks In Focus: ITI, Laurus Labs, L&T, JSW Steel & More | BQ Prime

Talking Point With Laurus Labs' Satyanarayana Chava

Laurus Labs' Management Shares Outlook For Q4 & Beyond

Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says

Laurus Labs In Focus | Ask Profit | NDTV Profit

Ideas for Profit | Laurus Labs - a diversified portfolio of APIs and formulations.

Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23

Laurus Labs Management On Q1 Report Card & More

Ideas for Profit | Laurus Labs

Laurus Labs' Growth Strategies For Q4 & Beyond

Q1 Review: Muted June Quarter For Laurus Labs

Laurus Labs In Focus | Profit Insight | NDTV Profit

Analysts' View On Buzzing Stocks Like HUL, ZEEL, Laurus Labs & More On Hot Money With Darshan Mehta

Yatharth Hospital's Q4 Net Profit Doubles; Subros Reports 65% Surge | NDTV Profit

Paras Defence: Order Inflow Outlook | NDTV Profit

IIT Campus Placements: 38% Of 2024 Batch Still Awaiting Jobs, Reveals RTI

Ask Profit | Sumitomo Chemical In Focus | NDTV Profit

Finance Minister Niramala Sitharaman Exclusive | NDTV Profit

Are IIT Placements In A Slump? | NDTV Profit